Exyte has completed the integration of Pharmaplan into its biopharma and life sciences division, creating a unified engineering…
Read More
South African Biotech Startup Immobazyme Secures R25m in Growth Funding to Advance Local Biopharma Production
South African biotech startup Immobazyme has secured an additional R25m ($1.45m) in growth funding, bringing its total capital raised to…
Read More
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
Teva (NYSE: TEVA) entered a license and supply agreement with Prestige Biopharma…
Read More
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
Quantum BioPharma Engages leading marketing firm MZ Digital and crowdfunding platform Dealcreater to successfully execute raise TORONTO, June 26, 2025…
Read More
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO
Quantum BioPharma This Offering Will Not Dilute Quantum BioPharma Shareholders TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd.…
Read More
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences
TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical…
Read More
